Edmonton, Canada
The company's core focus is on enabling broader access to the benefits of genome sequencing for the general public. Merogenomics Inc. is actively involved in raising awareness about the societal and economic value of genomic technologies, targeting governmental agencies, policy makers, industry stakeholders, patient advocacy groups, and commercial interests.
Their consulting services encompass a wide array of offerings including analyses of genetic and genomic-based tests available for private use, assistance in locating suitable services or tests, evaluation of specific genomic services or tests already undergone by the client, expert opinions based on the latest scientific evidence and access to professionals in the field, as well as assistance with support services related to whole genome sequencing.
With a focus on democratizing access to genomic sequencing, Merogenomics Inc. presents an intriguing opportunity for potential future venture capital investments as it strives to bridge the gap between genomic technologies and the general public, catering to an increasingly health-conscious global population.
